If you have questions, we have answers, just ask us!
Finding the right product doesn’t have to be overwhelming or expensive. To help you, the Meenta marketplace brings together the widest array of diagnostic products and laboratory services combined with world-class scientific expertise and clinical oversight all in one place.
Agilent Exome Sequencing Workflow
From: $13,717.00 per project
Meenta Inc. is partnering with genomics labs and Agilent to offer a complete Whole Exome Sequencing (WES) workflow, which can accommodate a wide variety of sample types (blood, fresh frozen tissue and FFPE), sample qualities, and DNA input amounts (10–200 ng).
Meenta and our genomics labs and Agilent to offer a complete Whole Exome Sequencing (WES) workflow, which can accommodate a wide variety of sample types (blood, fresh frozen tissue and FFPE), sample qualities, and DNA input amounts (10–200 ng). Perfect for hereditary and cancer genetics applications, this workflow uses the Agilent SureSelect human all exon kits (research, clinical, or custom) combined with the SureSelectXT low input reagent kits and SureSelect XT HS and XT low input enzymatic fragmentation kit. Then, using a NovaSeq 6000 (e.g. SP flow cell, 2 x 100 cycles for 16 samples), the host will provide at least 20x coverage of >94% of targeted bases (>5.3 GB/sample for SSEL V8 and >6.5GB/sample for SSEL CREv2). Targets protein-coding regions from RefSeq, GENCODE, CCDS, and UCSC known genes, including hard-to-capture exons that are omitted from other exomes.
- Generate libraries from as little as 10 ng of input from intact or highly fragmented FFPE DNA. Can also accommodate blood and fresh frozen tissue.
- Excellent overall uniformity and percent on-target enable variant calling with high confidence while reducing sequencing costs.
- Targets all pathogenic variants in the genes included in the American College of Medical Genetics guidelines for secondary findings.
Whole Exome Sequencing (WES) has become an essential tool for health care providers and clinical research laboratories using Next-Generation Sequencing (NGS). WES is a powerful tool for the identification of genetic variations involved in human diseases, notably in the detection of point mutations and copy number variations. Although NGS has been in use for over 15 years, library preparation reagents and sequencing technologies are constantly evolving to offer increased performance and flexibility in terms of content, sequencing requirements, and turnaround time.
Blood, fresh frozen tissue and FFPE
- Credit Card
- PO Number
Note: These products and services are not returnable.